Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening

Abstract

BackgroundBiotin–thiamine‐responsive basal ganglia disease (BTBGD) is an autosomal recessive neurometabolic disorder mostly presented in children. The disorder is described as having subacute encephalopathy with confusion, dystonia, and dysarthria triggered by febrile illness that leads to neuroregression and death if untreated. Using biotin and thiamine at an early stage of the disease can lead to significant improvement.MethodsBTBGD is a treatable disease if diagnosed at an early age and has been frequently reported in Saudi population. Keeping this in mind, the current study screened 3000 Saudi newborns for the SLC19A3 gene mutations using target sequencing, aiming to determine the carrier frequency in Saudi Population and whether BTBGD is a good candidate to be included in the newborn‐screened disorders.ResultsUsing targeted gene sequencing, DNA from 3000 newborns Saudi was screened for the SLC19A3 gene mutations using standard methods. Screening of the SLC19A3 gene revealed a previously reported heterozygous missense mutation (c.1264A>G (p.Thr422Ala) in six unrelated newborns. No probands having homozygous pathogenic mutations were found in the studied cohort. The variant has been frequently reported previously in homozygous state in Saudi population, making it a hot spot mutation. The current study showed that the carrier frequency of SLC19A3 gene mutation is 1 of 500 in Saudi newborns.ConclusionFor the first time in the literature, we determined the carrier frequency of SLC19A3 gene mutation in Saudi population. The estimated prevalence is too rare in Saudi population (at least one in million); therefore, the data are not in favor of including such very rare disorders in newborn screening program at population level. However, a larger cohort is needed for a more accurate estimate.

Case Report: Bi-allelic missense variant in the desmocollin 3 gene causes hypotrichosis and recurrent skin vesicles

“…Variant filtration was based on the family pedigree-inheritance pattern ( Figure 1A ) and the patient’s clinical presentation ( Figures 1B,E ). As pedigree depicted autosomal recessive inheritance pattern, bi-allelic and compound heterozygous variants that were rare and disease-causing were screened ( Alfadhel et al, 2019 ; Alhamoudi et al, 2021 ). Initial screening was performed using OMIM, HGMD, and variants were further classified according to ACMG guidelines.…”

Next-generation sequencing of Tunisian Leigh syndrome patients reveals novel variations: impact for diagnosis and treatment

“…Considering a case with adult-onset Wernicke’s-like encephalopathy a compound heterozygous variants Glu320 Gln combined with Lys44Glu were identified leading to a mild clinical manifestation [ 31 ]. Other than that, the hot spot variant identified Thr422Ala in the Saudi Arabian result in a somewhat mild phenotypes with a good prognosis [ 32 , 34 ]. As for the truncated variants, a Turkish patient harbored the SLC19A3 homozygous frameshift variant c.982del (p.Ala328Leufs*10), resulting in a truncated protein.…”

Novel homozygous pathogenic mitochondrial DNAJC19 variant in a patient with dilated cardiomyopathy and global developmental delay

“…The product size was 479 bp and the annealing temperature was (60°C). The product was sequenced by Sanger sequencing using capillary electrophoresis through ABI 3730xl (Alfadhel et al, 2019 ).…”